Search results
-
Blue Man Group: Creativity, Life and Surviving an Economic Meltdown
Chakravorti, Bhaskar; Kraus, Janet; Spence, Shirley M.Case HBS-810108-EEntrepreneurshipIn 2008, Blue Man Group's three co-founders are facing the prospect of losing not just a business but a way of life they have built together. The case follows the story of Chris Wink, Matt Goldman and Phil Stanton as they pursue their creative passion, and build the Blue Man Group from street performers to a performance arts empire with a global brand. The story has a personal as well as professional dimension to it, including the launch of the B...Starting at €8.20
-
Life Journey Profile: Mark Goldweitz
Chakravorti, Bhaskar; Spence, Shirley M.Case HBS-810112-EEntrepreneurshipExamine the life journey of an HBS 1969 alum, in his own words, and his perspective on success.Starting at €8.20
-
The Clinton Economic Program
Canals, JordiCase ASE-297-EEconomicsThis case sets the ground for a discussion of the main problems of the US economy in the 1990s and the new economic plan designed by President Clinton.Starting at €8.20
-
El programa económico de Clinton
Canals, JordiCase ASE-297EconomicsEste caso prepara el terreno para una discusión de los principales problemas de la economía de Estados Unidos en los años noventa y el nuevo plan económico diseñado por el presidente Clinton.Starting at €8.20
-
La reducción de impuestos del presidente Kennedy
Canals, JordiCase ASE-208EconomicsEl caso permite discutir la efectividad de la política fiscal para estimular la actividad económica. [Es una versión abreviada y modificada del caso The Tax Cut of 1964 (ASE-24)].Starting at €8.20
-
Life Journey Profile: Amee Chande
Chakravorti, Bhaskar; Spence, Shirley M.Case HBS-810110-EEntrepreneurshipExamine the life journey of an HBS 2002 alum, in her own words, and her perspective on success.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20